Ameriprise Financial Inc Vir Biotechnology, Inc. Transaction History

Ameriprise Financial Inc

  • $381 Billion
  • Q3 2024

A detailed history of Ameriprise Financial Inc transactions in Vir Biotechnology, Inc. stock. As of the latest transaction made, Ameriprise Financial Inc holds 267,414 shares of VIR stock, worth $1.98 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares
267,414
Previous 308,347 13.27%
Holding current value
$1.98 Million
Previous $2.74 Million 27.04%
% of portfolio
0.0%
Previous 0.0%

Shares

15 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024
SELL
$7.26 - $10.7 $297,173 - $437,983
-40,933 Reduced 13.27%
267,414 $2 Million
Q2 2024

Aug 14, 2024
SELL
$7.63 - $12.66 $108,567 - $180,139
-14,229 Reduced 4.41%
308,347 $2.74 Million
Q1 2024

May 15, 2024
BUY
$8.6 - $11.9 $84,486 - $116,905
9,824 Added 3.14%
322,576 $3.27 Million
Q4 2023

Feb 14, 2024
BUY
$7.76 - $10.29 $13,168 - $17,462
1,697 Added 0.55%
312,752 $3.15 Million
Q3 2023

Nov 14, 2023
BUY
$9.14 - $24.62 $319,004 - $859,287
34,902 Added 12.64%
311,055 $2.91 Million
Q2 2023

Aug 14, 2023
SELL
$23.2 - $27.29 $635,355 - $747,363
-27,386 Reduced 9.02%
276,153 $6.77 Million
Q1 2023

May 15, 2023
SELL
$22.26 - $30.85 $75,372 - $104,458
-3,386 Reduced 1.1%
303,539 $7.06 Million
Q4 2022

Feb 14, 2023
SELL
$19.96 - $28.22 $5.4 Million - $7.63 Million
-270,452 Reduced 46.84%
306,925 $7.77 Million
Q3 2022

Nov 14, 2022
BUY
$18.26 - $31.1 $4.77 Million - $8.13 Million
261,479 Added 82.77%
577,377 $11.1 Million
Q2 2022

Aug 15, 2022
BUY
$19.08 - $26.7 $5.69 Million - $7.96 Million
298,022 Added 1667.16%
315,898 $8.05 Million
Q1 2022

May 16, 2022
BUY
$21.19 - $40.01 $77,216 - $145,796
3,644 Added 25.6%
17,876 $459,000
Q4 2021

Feb 14, 2022
BUY
$30.97 - $54.03 $27,253 - $47,546
880 Added 6.59%
14,232 $596,000
Q3 2021

Nov 15, 2021
SELL
$34.9 - $54.54 $6,980 - $10,908
-200 Reduced 1.48%
13,352 $581,000
Q2 2021

Aug 16, 2021
BUY
$38.75 - $51.0 $4,068 - $5,355
105 Added 0.78%
13,552 $641,000
Q1 2021

May 17, 2021
BUY
$26.34 - $83.07 $354,193 - $1.12 Million
13,447 New
13,447 $689,000

Others Institutions Holding VIR

# of Institutions
218
Shares Held
87M
Call Options Held
127K
Put Options Held
1.19M
View Full List

About Vir Biotechnology, Inc.

VIR Quotes by TradingView
  • Ticker VIR
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 132,638,000
  • Market Cap $982M
  • Description
  • Vir Biotechnology, Inc., a commercial-stage immunology company, develops therapeutic products to treat and prevent serious infectious diseases. It develops Sotrovimab (VIR-7832), a SARS-CoV-2-neutralizing mAbs to treat and prevent COVID-19 infection under the Xevudy brand; VIR-2218 and VIR-3434 for the treatment of hepatitis B virus; VIR-2482 fo...
More about VIR
Track This Portfolio

Track Ameriprise Financial Inc Portfolio

Follow Ameriprise Financial Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Ameriprise Financial Inc, based on Form 13F filings with the SEC.

News

Stay updated on Ameriprise Financial Inc with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email